SyB C-0501(Oral Bendamustine) in Patients With Advanced Solid Tumors
Clinical trial NCT03604679 · COMPLETED
Trial details
- NCT number
- NCT03604679
- Sponsor
- SymBio Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-24
- Primary completion
- 2020-09-11
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.